A drug called Myforix-360 mycofenolate sodium tablet USP is essential in avoiding organ rejection in those who have received solid organ transplants. The immunosuppressant medication mycophenolate sodium is the active component of this pill. By preventing immune cells from proliferating, mycophenolate sodium lessens the immune system's reaction to the donated organ. By doing this, Myforix-360 Mycofenolate Sodium Tablet USP aids in keeping the transplanted organ operating normally and preventing the body from rejecting it.
Product details
Country of Origin |
Made in India |
Form |
Tablet |
Packaging Size |
10 X 10 |
Dose/Strength |
360 |
Brand |
Mycofenolate Sodium |
Manufacturer |
Brix Biopharma |
Packaging size |
10*10 Tablets |
Packaging Type |
Box |
Prescription / Non prescription |
Prescription |
Shelf life |
24 Months |
Strength |
360 mg |
Usage/Application |
To Prevent organ transplant rejection |
DHEER HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |